JP2020502229A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020502229A5 JP2020502229A5 JP2019534192A JP2019534192A JP2020502229A5 JP 2020502229 A5 JP2020502229 A5 JP 2020502229A5 JP 2019534192 A JP2019534192 A JP 2019534192A JP 2019534192 A JP2019534192 A JP 2019534192A JP 2020502229 A5 JP2020502229 A5 JP 2020502229A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pyran
- compound
- methyl
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022019891A JP7286825B2 (ja) | 2016-12-22 | 2022-02-10 | Ｃｙｐ１１ａ１（チトクロムｐ４５０モノオキシゲナーゼ１１ａ１）阻害剤としてのピラン誘導体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20166024 | 2016-12-22 | ||
| FI20166024 | 2016-12-22 | ||
| PCT/FI2017/050926 WO2018115591A1 (en) | 2016-12-22 | 2017-12-21 | Pyran dervatives as cyp11a1 (cytochrome p450 monooxygenase 11a1) inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022019891A Division JP7286825B2 (ja) | 2016-12-22 | 2022-02-10 | Ｃｙｐ１１ａ１（チトクロムｐ４５０モノオキシゲナーゼ１１ａ１）阻害剤としてのピラン誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020502229A JP2020502229A (ja) | 2020-01-23 |
| JP2020502229A5 true JP2020502229A5 (https=) | 2021-09-30 |
| JP7025432B2 JP7025432B2 (ja) | 2022-02-24 |
Family
ID=61005837
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019534192A Active JP7025432B2 (ja) | 2016-12-22 | 2017-12-21 | Ｃｙｐ１１ａ１（チトクロムｐ４５０モノオキシゲナーゼ１１ａ１）阻害剤としてのピラン誘導体 |
| JP2022019891A Active JP7286825B2 (ja) | 2016-12-22 | 2022-02-10 | Ｃｙｐ１１ａ１（チトクロムｐ４５０モノオキシゲナーゼ１１ａ１）阻害剤としてのピラン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022019891A Active JP7286825B2 (ja) | 2016-12-22 | 2022-02-10 | Ｃｙｐ１１ａ１（チトクロムｐ４５０モノオキシゲナーゼ１１ａ１）阻害剤としてのピラン誘導体 |
Country Status (30)
| Country | Link |
|---|---|
| US (4) | US10717726B2 (https=) |
| EP (2) | EP3558981B1 (https=) |
| JP (2) | JP7025432B2 (https=) |
| KR (3) | KR102491308B1 (https=) |
| CN (2) | CN116162084B (https=) |
| AR (1) | AR110412A1 (https=) |
| AU (2) | AU2017380282B2 (https=) |
| CA (1) | CA3047370A1 (https=) |
| CL (1) | CL2019001728A1 (https=) |
| CO (1) | CO2019007321A2 (https=) |
| CY (1) | CY1124461T1 (https=) |
| DK (1) | DK3558981T3 (https=) |
| EA (1) | EA039309B1 (https=) |
| ES (1) | ES2880151T3 (https=) |
| HR (1) | HRP20211255T1 (https=) |
| HU (1) | HUE056540T2 (https=) |
| IL (2) | IL267484B (https=) |
| LT (1) | LT3558981T (https=) |
| MA (2) | MA47102B1 (https=) |
| MX (1) | MX388538B (https=) |
| PE (1) | PE20191137A1 (https=) |
| PH (1) | PH12019550111A1 (https=) |
| PL (1) | PL3558981T3 (https=) |
| PT (1) | PT3558981T (https=) |
| RS (1) | RS62198B1 (https=) |
| SI (1) | SI3558981T1 (https=) |
| TN (1) | TN2019000189A1 (https=) |
| TW (2) | TWI762544B (https=) |
| UA (1) | UA124640C2 (https=) |
| WO (1) | WO2018115591A1 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR110412A1 (es) * | 2016-12-22 | 2019-03-27 | Orion Corp | Inhibidores de la cyp11a1 |
| AU2021269872A1 (en) * | 2020-05-14 | 2022-11-24 | Orion Corporation | CYP11A1 inhibitors |
| CA3200556A1 (en) * | 2020-12-01 | 2021-11-30 | David Din Belle | 2,3-dihydro-4h-benzo[b][1,4]oxazin-4-yl)(5-(phenyl)-pyridin-3-yl)methanone derivatives and similar compounds as cyp11a1 inhibitors for the treatment of prostate cancer |
| AR124985A1 (es) * | 2021-03-01 | 2023-05-24 | Orion Corp | Nuevas formas de sal de un inhibidor de cyp11a1 estructurado en 4h-piran-4-ona |
| EP4301749A1 (en) | 2021-03-01 | 2024-01-10 | Orion Corporation | Solid forms of a 4h-pyran-4-one structured cyp11a1 inhibitor |
| WO2022184975A1 (en) * | 2021-03-01 | 2022-09-09 | Orion Corporation | Process for the preparation of a cyp11a1 inhibitor and intermediates thereof |
| BR112023027282A2 (pt) | 2021-06-23 | 2024-03-12 | Orion Corp | Processos para a preparação de compostos inibidores de cyp11a1 e compostos intermediários dos mesmos |
| PE20241583A1 (es) * | 2021-09-28 | 2024-08-01 | Orion Corp | Inhibidor de cyp11a1 para su uso en el tratamiento del cancer de prostata |
| EP4422755A1 (en) | 2021-10-28 | 2024-09-04 | Orion Corporation | Salt forms of a 4h-pyran-4-one structured cyp11 at inhibitor |
| WO2023084158A1 (en) | 2021-11-10 | 2023-05-19 | Orion Corporation | Cyp11a1 inhibitors |
| ES3059214T3 (en) | 2022-01-20 | 2026-03-19 | Orion Corp | Pharmaceutical composition of a cyp11a1 inhibitor |
| JP7645296B2 (ja) * | 2022-02-08 | 2025-03-13 | ディーエヌエフ カンパニー リミテッド | ヨウ素含有金属化合物およびこれを含む薄膜蒸着用組成物 |
| CN118307519A (zh) * | 2023-01-06 | 2024-07-09 | 上海闻耐医药科技有限公司 | 一类cyp11a1抑制剂化合物及其制备方法和用途 |
| KR20240126916A (ko) | 2023-02-14 | 2024-08-22 | 경북대학교 산학협력단 | Asm 단백질 또는 이의 단편을 포함하는 퇴행성 신경질환 또는 우울증 예방 또는 치료용 조성물 |
| WO2024199262A1 (zh) * | 2023-03-29 | 2024-10-03 | 西藏海思科制药有限公司 | Cyp11a1抑制剂及其用途 |
| CN121039123A (zh) | 2023-04-21 | 2025-11-28 | 西藏海思科制药有限公司 | Cyp11a1抑制剂及其用途 |
| AU2024270498A1 (en) * | 2023-05-11 | 2025-11-27 | Foshan Ionova Biotherapeutics Co., Inc. | Novel compounds as cyp11a1 inhibitors and methods of use thereof |
| WO2025017072A1 (en) | 2023-07-19 | 2025-01-23 | Orion Corporation | Stable pharmaceutical compositions of a cyp11a1 inhibitor |
| CN121605106A (zh) * | 2023-07-27 | 2026-03-03 | 优领医药科技(香港)有限公司 | Cyp11a1抑制剂 |
| CN121889383A (zh) * | 2023-09-08 | 2026-04-17 | 深圳众格生物科技有限公司 | 一种cyp11a1抑制剂、其制备方法及其应用 |
| WO2025168117A1 (zh) * | 2024-02-08 | 2025-08-14 | 盛睿泽华医药科技（苏州）有限公司 | 一种多环化合物及其制备方法和应用 |
| WO2025237211A1 (zh) * | 2024-05-11 | 2025-11-20 | 辽宁海思科制药有限公司 | 一种cyp11a1抑制剂的晶型物及其制备方法和应用 |
| WO2025247149A1 (zh) * | 2024-05-27 | 2025-12-04 | 辽宁海思科制药有限公司 | 一种cyp11a1抑制剂的盐及其晶型、其制备方法和应用 |
| WO2026040949A1 (zh) * | 2024-08-19 | 2026-02-26 | 辽宁海思科制药有限公司 | 一种cyp11a1抑制剂的药物组合物及其制备方法和用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6176485A (ja) * | 1984-09-20 | 1986-04-18 | Ss Pharmaceut Co Ltd | 新規なγ−ピラン誘導体 |
| US7344700B2 (en) * | 2002-02-28 | 2008-03-18 | University Of Tennessee Research Corporation | Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy |
| EP1471063A1 (en) * | 2003-02-28 | 2004-10-27 | Exonhit Therapeutics S.A. | Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis |
| US20140005181A1 (en) * | 2012-06-21 | 2014-01-02 | Sanford-Burnham Medical Research Institute | Small molecule antagonists of the apelin receptor for the treatment of disease |
| TW201534586A (zh) * | 2013-06-11 | 2015-09-16 | Orion Corp | 新穎ｃｙｐ１７抑制劑／抗雄激素劑 |
| AR110412A1 (es) * | 2016-12-22 | 2019-03-27 | Orion Corp | Inhibidores de la cyp11a1 |
-
2017
- 2017-12-20 AR ARP170103609A patent/AR110412A1/es active IP Right Grant
- 2017-12-21 TW TW106145006A patent/TWI762544B/zh active
- 2017-12-21 EP EP17832250.9A patent/EP3558981B1/en active Active
- 2017-12-21 LT LTEP17832250.9T patent/LT3558981T/lt unknown
- 2017-12-21 MX MX2019007373A patent/MX388538B/es unknown
- 2017-12-21 TW TW111114824A patent/TWI796205B/zh active
- 2017-12-21 DK DK17832250.9T patent/DK3558981T3/da active
- 2017-12-21 KR KR1020197021256A patent/KR102491308B1/ko active Active
- 2017-12-21 CN CN202211597796.4A patent/CN116162084B/zh active Active
- 2017-12-21 PE PE2019001297A patent/PE20191137A1/es unknown
- 2017-12-21 MA MA47102A patent/MA47102B1/fr unknown
- 2017-12-21 UA UAA201908272A patent/UA124640C2/uk unknown
- 2017-12-21 CN CN201780079479.4A patent/CN110139861B/zh active Active
- 2017-12-21 KR KR1020237002074A patent/KR102826021B1/ko active Active
- 2017-12-21 SI SI201730841T patent/SI3558981T1/sl unknown
- 2017-12-21 EP EP21165964.4A patent/EP3868756A1/en not_active Withdrawn
- 2017-12-21 PT PT178322509T patent/PT3558981T/pt unknown
- 2017-12-21 AU AU2017380282A patent/AU2017380282B2/en active Active
- 2017-12-21 CA CA3047370A patent/CA3047370A1/en active Pending
- 2017-12-21 HU HUE17832250A patent/HUE056540T2/hu unknown
- 2017-12-21 ES ES17832250T patent/ES2880151T3/es active Active
- 2017-12-21 RS RS20210994A patent/RS62198B1/sr unknown
- 2017-12-21 EA EA201991513A patent/EA039309B1/ru unknown
- 2017-12-21 TN TNP/2019/000189A patent/TN2019000189A1/en unknown
- 2017-12-21 WO PCT/FI2017/050926 patent/WO2018115591A1/en not_active Ceased
- 2017-12-21 HR HRP20211255TT patent/HRP20211255T1/hr unknown
- 2017-12-21 KR KR1020257020993A patent/KR20250097993A/ko active Pending
- 2017-12-21 JP JP2019534192A patent/JP7025432B2/ja active Active
- 2017-12-21 MA MA055983A patent/MA55983A/fr unknown
- 2017-12-21 PL PL17832250T patent/PL3558981T3/pl unknown
- 2017-12-21 US US16/472,377 patent/US10717726B2/en active Active
-
2019
- 2019-06-19 IL IL267484A patent/IL267484B/en unknown
- 2019-06-20 CL CL2019001728A patent/CL2019001728A1/es unknown
- 2019-06-21 PH PH12019550111A patent/PH12019550111A1/en unknown
- 2019-07-09 CO CONC2019/0007321A patent/CO2019007321A2/es unknown
-
2020
- 2020-06-08 US US16/895,221 patent/US11098032B2/en active Active
-
2021
- 2021-05-28 AU AU2021203497A patent/AU2021203497B2/en active Active
- 2021-07-06 US US17/367,849 patent/US12030871B2/en active Active
- 2021-08-19 IL IL285729A patent/IL285729B/en unknown
- 2021-08-25 CY CY20211100760T patent/CY1124461T1/el unknown
-
2022
- 2022-02-10 JP JP2022019891A patent/JP7286825B2/ja active Active
-
2024
- 2024-05-24 US US18/674,603 patent/US20240308989A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020502229A5 (https=) | ||
| HRP20211255T1 (hr) | Derivati pirana kao inhibitori cyp11a1 (citokrom p450 monooksigenaze 11a1) | |
| RU2323215C2 (ru) | Замещенные производные хиназолина как ингибиторы ауроракиназы | |
| ES2205035T3 (es) | Sulfonilfenilheterociclos substituidos como inhibidores de la ciclooxigenasa-2 y de la 5-lipoxigenasa. | |
| RU2439068C2 (ru) | Модуляторы mglur5 | |
| ME00427B (me) | N-supstituisani hidroksipiramidinon karboksamidni inhibitori hiv integraze | |
| JP2018502925A5 (https=) | ||
| JP2018502906A5 (https=) | ||
| RU2016137674A (ru) | Производные пиперидиндиона | |
| HRP20230294T1 (hr) | Modulatori tmem16a | |
| HRP20130120T1 (hr) | Analozi piridona i piridazona kao gpr119 modulatori | |
| NZ724602A (en) | Ror-gamma modulators and uses thereof | |
| RU2019132212A (ru) | Селективные ингибиторы hdac6 | |
| NZ596071A (en) | Oxazole substituted indazoles as pi3-kinase inhibitors | |
| RU2014108140A (ru) | Соединение на основе хинозолина в качестве ингибиторов серен-треониновых киназ | |
| JP2006503081A5 (https=) | ||
| JP2015526441A5 (https=) | ||
| AR065814A1 (es) | Derivados de 5-fenilimidazolona,inhibidores de beta-secretasa,composiciones farmaceuticas que los contienen y usos para prevenir y/o tratar trastornos asociados a niveles beta-amiloides elevados. | |
| JP2012509936A5 (https=) | ||
| JP2016530213A5 (https=) | ||
| WO2010007966A1 (ja) | アゾール化合物 | |
| JP2019535658A5 (https=) | ||
| JP2016514711A5 (https=) | ||
| US11660301B2 (en) | Combination of ATR kinase inhibitors with PARP inhibitors | |
| RU2019117958A (ru) | Производные индола, полезные в качестве ингибиторов диацилглицерид-о-ацилтрансферазы 2 |